Nicox SA - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Nicox SA. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Nicox SA. The Group's principal activity is to develop nitric-oxide donating drugs targeting the therapeutic area. The Group offers biopharmaceutical therapeutics to treat ailments such as osteoarthritis, diabetes, inflammation and cardio metabolic diseases. The Group markets its products under the brand names Naproxcinod, NCX 4016 and NCX 6560. The Group also works in association with major pharmaceutical companies such as Pfizer, Merck and Group Ferrer. The Group operates in France.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report